Abstract:OBJECTIVES:Gene transfer to cardiomyocytes in vivo has received much research attention in the last decade but remains a substantial hurdle. Gene transfer using ultrasound-targeted microbubble destruction is a promising tool for gene therapy. Little data have shown the feasibility and optimization of this method for primary myocardial disease. In this study, we sought to determine the feasibility and efficiency of in vivo gene transfer to the myocardium mediated by ultrasound-targeted microbubble destruction accompanied by polyethylenimine.METHODS:Three plasmids (luciferase reporter, red fluorescent protein reporter, and enhanced green fluorescent protein reporter) were used in this study. The ultrasound parameters were also optimized. A solution containing phosphate-buffered saline, a plasmid, plasmid complex, or polyethylenimine/plasmid, and liposome microbubbles was injected via a tail vein with (study) or without (control) transthoracic ultrasound irradiation. The efficiency of reporter gene transfer was determined by detection of luciferase activity or microscopy, and histologic investigations of the tissue specimens were performed.RESULTS:Ultrasound-targeted microbubble destruction significantly increased luciferase activity in vivo compared to plasmids and microbubbles alone (P < .001). More importantly, the increase in transgene expression was significantly related to ultrasound-targeted microbubble destruction in the presence of polyethylenimine (P < .001). In addition, fluorescein expression was present in all sections that received ultrasound-targeted microbubble destruction. The fluorescent reporter genes and luciferase plasmid all had similar results. Regardless of ultrasound exposure, expression in other organs was close to a background level except for the liver and lung. Hematoxylin-eosin staining showed no notable myocardial injury or death in control and treated mice.CONCLUSIONS:An atraumatic targeted gene delivery technique based on ultrasound-targeted microbubble destruction and polyethylenimine has been developed to transfect cardiomyocytes in vivo. If a suitable target gene is added, the novel technique could be highly effective in many kinds of heart disease.

Ultrasound Targeted Microbubble Destruction-Mediated Gene Delivery System: Application to Therapy for Ocular Disease

Gene Therapy for Ocular Diseases Meditated by Ultrasound and Microbubbles (Review)

Research of Ultrasound-Mediated Gene Delivery

Echogenic PEGylated PEI-Loaded Microbubble As Efficient Gene Delivery System.

Nanoparticles in the Ocular Drug Delivery

Advances in Microbubble-Assisted Ultrasound-Guided Gene Therapy: Mechanisms and Applications

&Lt;p>echogenic PEGylated PEI-Loaded Microbubble As Efficient Gene Delivery System</p>

Combined Ultrasound-Targeted Microbubble Destruction and Polyethylenimine-Mediated Plasmid Dna Delivery to the Rat Retina: Enhanced Efficiency and Accelerated Expression

Use of Cationic Microbubbles Targeted to P-selectin to Improve Ultrasound-Mediated Gene Transfection of Hvegf165 to the Ischemic Myocardium

The Present and Future Role of Ultrasound Targeted Microbubble Destruction in Preclinical Studies of Cardiac Gene Therapy

Highlights in ultrasound-targeted microbubble destruction-mediated gene/drug delivery strategy for treatment of malignancies.

Ultrasound-targeted Microbubble Destruction Enhances Polyethylenimine-Mediated Gene Transfection in Vitro in Human Retinal Pigment Epithelial Cells and in Vivo in Rat Retina.

AAV for Gene Therapy in Ocular Diseases: Progress and Prospects

Lipid nanoparticle technology-mediated therapeutic gene manipulation in the eyes

Advanced micro/nano-electroporation for gene therapy: recent advances and future outlook.

Ultrasound- and Liposome Microbubble-Mediated Targeted Gene Transfer to Cardiomyocytes in Vivo Accompanied by Polyethylenimine.

Advanced Micro/Nano-Electroporation for Gene Therapy: Recent Advances and Future Outlook

Intraocular Sirna Delivery Mediated by Penetratin Derivative to Silence Orthotopic Retinoblastoma Gene

Gene-based therapeutic tools in the treatment of Cornea Disease.

Progress and preclinical application status of ultrasound microbubbles

Nanomedicine and drug delivery to the retina: current status and implications for gene therapy